Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC
Clinical trial NCT04630730 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04630730
- Sponsor
- Swiss Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-24
- Primary completion
- 2026-06-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.